iKang Healthcare (KANG) Reports Q1 EPS of $0.06/ADS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/27/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Fox Factory sells Marucci Sports for $225M, cuts debt
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
iKang Announces Unaudited Financial Results for the Fiscal First Quarter Ended June 30, 2017
September 14, 2017 5:00 PM EDTBEIJING, Sept. 14, 2017 (GLOBE NEWSWIRE) -- iKang Healthcare Group, Inc. (iKang or the Company) (NASDAQ: KANG), a major provider in Chinas fast growing private preventive healthcare services market, today announced its unaudited financial results for the first quarter ended June 30, 2017.
Fiscal First Quarter Ended June 30, 2017 Financial Highlights
Net revenues were US$115.6 million, an increase of 14.2% year-over-year (an increase of 19.9% on RMB basis)(1) Gross profit was US$48.4 million, an increase of 8.1% year-over-year (an increase of 13.5% on RMB basis)(1) Net income attributable to the Company was US$3.6... More